VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 235 filers reported holding VERACYTE INC in Q1 2021. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $163 | +81.1% | 7,345 | +105.7% | 0.00% | – |
| Q2 2023 | $90 | +13.9% | 3,570 | 0.0% | 0.00% | – |
| Q1 2023 | $79 | -94.0% | 3,570 | -93.6% | 0.00% | -100.0% |
| Q4 2022 | $1,324 | -99.6% | 55,812 | +172.3% | 0.00% | – |
| Q3 2022 | $339,000 | +294.2% | 20,495 | +371.6% | 0.00% | – |
| Q2 2022 | $86,000 | -8.5% | 4,346 | +27.4% | 0.00% | – |
| Q1 2022 | $94,000 | -2.1% | 3,410 | +46.3% | 0.00% | – |
| Q4 2021 | $96,000 | +45.5% | 2,331 | +62.4% | 0.00% | – |
| Q3 2021 | $66,000 | -26.7% | 1,435 | -14.4% | 0.00% | – |
| Q1 2021 | $90,000 | +50.0% | 1,677 | +34.8% | 0.00% | – |
| Q4 2020 | $60,000 | -34.1% | 1,244 | -64.8% | 0.00% | – |
| Q2 2020 | $91,000 | +51.7% | 3,534 | +61.9% | 0.00% | – |
| Q4 2019 | $60,000 | +233.3% | 2,183 | +186.1% | 0.00% | – |
| Q3 2019 | $18,000 | – | 763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |